Back to Search
Start Over
Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values.
- Source :
-
International journal of antimicrobial agents [Int J Antimicrob Agents] 2020 Jul; Vol. 56 (1), pp. 106011. Date of Electronic Publication: 2020 May 15. - Publication Year :
- 2020
-
Abstract
- Introduction: This study examined ceftazidime-avibactam activity against carbapenem-resistant Enterobacterales (CRE) clinical isolates and resistance mechanisms among non-metallo β-lactamase (MBL) producers displaying ceftazidime-avibactam MIC values at 4 mg/L.<br />Methods: CRE isolates (286 of 8161 Enterobacterales) collected in Asia-Pacific, Europe and Latin America during 2016 were screened for carbapenemase genes. Selected isolates were susceptibility tested for ceftazidime-avibactam in the presence or absence of phenylalanine-arginyl β-naphthylamide (PAβN) and polymyxin B nonapeptide (PMBN). Genome sequences were investigated for the integrity of outer membrane protein (OMP) genes and multilocus sequence typing. qRT-PCR assays were conducted to determine expression of acrA, ampC, and OMP genes.<br />Results: Ceftazidime-avibactam inhibited 99.2% of the Enterobacterales, 22 (78.7%) of the 286 CRE and 226 (100%) non-MBL producers. Among carbapenemase producers (85.3%; 244 of 286), the most common gene was bla <subscript>KPC</subscript> (76 bla <subscript>KPC-3</subscript> and 46 bla <subscript>KPC-2</subscript> ), followed by bla <subscript>OXA-48</subscript> -like (60 isolates) and bla <subscript>NDM</subscript> (37). Ceftazidime-avibactam MIC values at 4 mg/L were noted among 14 Klebsiella pneumoniae (13 carrying bla <subscript>KPC</subscript> and 1 bla <subscript>CTX-M-15</subscript> ) mostly from Italy and Brazil and 1 Klebsiella aerogenes overexpressing ampC. PAβN did not significantly decrease ceftazidime-avibactam results, but adding PMBN did significantly decrease the MIC results for the combination. All K. pneumoniae isolates had a premature stop codon at OmpK35 and most isolates had L3 alterations of OmpK36, low expression of this gene, or OmpC disruption (K. aerogenes). Nine K. pneumoniae isolates belonged to clonal complex 258 and displayed intrahospital clonality.<br />Conclusion: Ceftazidime-avibactam is an important addition to the armamentarium against multidrug-resistant organisms, and elevated MIC results for this combination seem to be associated with L3 OmpK36 alterations and β-lactamases able to hydrolyze ceftazidime.<br /> (Copyright © 2020. Published by Elsevier B.V.)
- Subjects :
- Bacterial Outer Membrane Proteins genetics
Bacterial Proteins metabolism
Carbapenem-Resistant Enterobacteriaceae drug effects
Carbapenem-Resistant Enterobacteriaceae isolation & purification
Drug Combinations
Drug Resistance, Multiple, Bacterial genetics
Enterobacter aerogenes drug effects
Enterobacter aerogenes genetics
Enterobacter aerogenes isolation & purification
Humans
Klebsiella pneumoniae drug effects
Klebsiella pneumoniae isolation & purification
Membrane Transport Proteins genetics
Microbial Sensitivity Tests
Multilocus Sequence Typing
Phenylalanine analogs & derivatives
Phenylalanine pharmacology
Polymyxin B analogs & derivatives
Polymyxin B pharmacology
beta-Lactamases metabolism
Anti-Bacterial Agents pharmacology
Azabicyclo Compounds pharmacology
Bacterial Proteins genetics
Carbapenem-Resistant Enterobacteriaceae genetics
Ceftazidime pharmacology
Klebsiella pneumoniae genetics
Porins genetics
beta-Lactamase Inhibitors pharmacology
beta-Lactamases genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1872-7913
- Volume :
- 56
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- International journal of antimicrobial agents
- Publication Type :
- Academic Journal
- Accession number :
- 32417206
- Full Text :
- https://doi.org/10.1016/j.ijantimicag.2020.106011